Invesco Biotechnology & Genome ETF (PBE) Holdings $68.20 -0.26 (-0.38%) Closing price 04:10 PM EasternExtended Trading$68.17 -0.03 (-0.04%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 PBE HoldingsRankCompanyCurrent PriceWeightShares Held1ALNYAlnylam Pharmaceuticals$452.33-0.4%7.46%38,4842ILMNIllumina$99.17-0.4%5.76%135,3433RPRXRoyalty Pharma$35.62-1.2%5.63%341,5234BMRNBioMarin Pharmaceutical$57.68-1.7%5.09%192,1255AMGNAmgen$285.61-0.8%5.07%39,9516GILDGilead Sciences$112.56-1.2%5.03%102,3407UTHRUnited Therapeutics$307.24+0.6%4.73%35,4608VRTXVertex Pharmaceuticals$392.05+0.8%4.19%25,0319AVXLAnavex Life Sciences$9.22-2.4%4.13%826,27810INCYIncyte$83.70-1.3%3.25%93,186 Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 11HALOHalozyme Therapeutics$72.81-0.5%3.10%111,90212DVAXDynavax Technologies$10.27+0.1%3.07%622,66513COLLCollegium Pharmaceutical$38.35-1.1%3.03%206,56914QGENQiagen$46.07-4.0%2.99%138,87415ACADACADIA Pharmaceuticals$26.23-1.3%2.98%274,43416PTGXProtagonist Therapeutics$58.14-5.4%2.98%131,15917FOLDAmicus Therapeutics$7.65+0.1%2.95%975,90818PTCTPTC Therapeutics$49.79+0.0%2.85%127,23919ARWRArrowhead Pharmaceuticals$22.34+2.5%2.83%396,20620NBIXNeurocrine Biosciences$138.94+0.6%2.78%49,65521VCYTVeracyte$29.95+4.7%2.68%217,72222RGENRepligen$122.17+2.8%2.51%49,69623EXELExelixis$37.90-1.6%2.35%141,32424MNKDMannKind$4.49-0.7%2.21%1,448,19725TGTXTG Therapeutics$28.96+1.4%2.15%172,805 Geographic ExposureUnited States97.1%Netherlands2.8%Currency ExposureUSD97.1%Sector ExposureHealth Care97.1%Materials2.8%Industry ExposureBiotechnology84.7%Health Care Equipment & Supplies12.4%Metals & Mining2.8%SubIndustry ExposureBiotechnology84.7%Life Sciences Tools & Services10.5%Diversified Metals & Mining2.8%Health Care Equipment1.9% Related Companies and Tools Related Companies Direxion Daily Healthcare Bull 3x Shares Portfolio Invesco Pharmaceuticals ETF Portfolio SPDR S&P Pharmaceuticals ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio Simplify Health Care ETF Portfolio KraneShares MSCI All China Health Care Index ETF Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio VanEck Biotech ETF Portfolio Direxion Daily S&P Biotech Bear 3x Shares Portfolio This page (NYSEARCA:PBE) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access